Korro Bio, Inc.

NASDAQ

Market Cap.

127.15M

Avg. Volume

138.95K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Korro Bio, Inc.

Korro Bio, Inc. News

Korro Bio, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareBiotechnology
korrobio.com

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Korro Bio, Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Korro Bio, Inc. Financials

Table Compare

Compare KRRO metrics with:

   

Earnings & Growth

KRRO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

KRRO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

KRRO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

KRRO

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Korro Bio, Inc. Income

Korro Bio, Inc. Balance Sheet

Korro Bio, Inc. Cash Flow

Korro Bio, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Korro Bio, Inc. Executives

NameRole
Dr. Ram Aiyar MBA, Ph.D.Chief Executive Officer, President & Director
Mr. Vineet Agarwal M.B.A.Chief Financial Officer
Dr. Kemi Olugemo M.D.Chief Medical Officer
Mr. Jeffrey M. Cerio J.D., Pharm.D.Senior Vice President, General Counsel & Corporate Secretary
Mr. Andrew Fraley Ph.D.Co-Founder & Advisor
NameRoleGenderDate of BirthPay
Dr. Ram Aiyar MBA, Ph.D.Chief Executive Officer, President & Director1978939.08K
Mr. Vineet Agarwal M.B.A.Chief Financial OfficerMale1982811.77K
Dr. Kemi Olugemo M.D.Chief Medical Officer1977649.72K
Mr. Jeffrey M. Cerio J.D., Pharm.D.Senior Vice President, General Counsel & Corporate SecretaryMale615.03K
Mr. Andrew Fraley Ph.D.Co-Founder & AdvisorMale

--

Korro Bio, Inc. Insider Trades

Date11 Jun
NameBehbahani Ali
RoleDirector, 10 percent owner
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameMeyers Rachel
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameBermingham Nessan
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameKnobil Katharine
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameFORMELA JEAN FRANCOIS
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
DateNameRoleTransactionTypeShares
11 JunBehbahani AliDirector, 10 percent ownerAcquiredA-Award6010
11 JunMeyers RachelDirectorAcquiredA-Award6010
11 JunBermingham NessanDirectorAcquiredA-Award6010
11 JunKnobil KatharineDirectorAcquiredA-Award6010
11 JunFORMELA JEAN FRANCOISDirectorAcquiredA-Award6010

Discover More

Streamlined Academy

Korro Bio, Inc.

NASDAQ

Market Cap.

127.15M

Avg. Volume

138.95K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Korro Bio, Inc. News

Korro Bio, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Korro Bio, Inc. Earnings & Revenue

Korro Bio, Inc. Income

Korro Bio, Inc. Balance Sheet

Korro Bio, Inc. Cash Flow

Korro Bio, Inc. Financials Over Time

Korro Bio, Inc. Executives

NameRole
Dr. Ram Aiyar MBA, Ph.D.Chief Executive Officer, President & Director
Mr. Vineet Agarwal M.B.A.Chief Financial Officer
Dr. Kemi Olugemo M.D.Chief Medical Officer
Mr. Jeffrey M. Cerio J.D., Pharm.D.Senior Vice President, General Counsel & Corporate Secretary
Mr. Andrew Fraley Ph.D.Co-Founder & Advisor
NameRoleGenderDate of BirthPay
Dr. Ram Aiyar MBA, Ph.D.Chief Executive Officer, President & Director1978939.08K
Mr. Vineet Agarwal M.B.A.Chief Financial OfficerMale1982811.77K
Dr. Kemi Olugemo M.D.Chief Medical Officer1977649.72K
Mr. Jeffrey M. Cerio J.D., Pharm.D.Senior Vice President, General Counsel & Corporate SecretaryMale615.03K
Mr. Andrew Fraley Ph.D.Co-Founder & AdvisorMale

--

Korro Bio, Inc. Insider Trades

Date11 Jun
NameBehbahani Ali
RoleDirector, 10 percent owner
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameMeyers Rachel
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameBermingham Nessan
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameKnobil Katharine
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
Date11 Jun
NameFORMELA JEAN FRANCOIS
RoleDirector
TransactionAcquired
TypeA-Award
Shares6010
DateNameRoleTransactionTypeShares
11 JunBehbahani AliDirector, 10 percent ownerAcquiredA-Award6010
11 JunMeyers RachelDirectorAcquiredA-Award6010
11 JunBermingham NessanDirectorAcquiredA-Award6010
11 JunKnobil KatharineDirectorAcquiredA-Award6010
11 JunFORMELA JEAN FRANCOISDirectorAcquiredA-Award6010

Streamlined Academy

Website screenshot
HealthcareBiotechnology
korrobio.com

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Korro Bio, Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Korro Bio, Inc. Financials

Table Compare

Compare KRRO metrics with:

   

Earnings & Growth

KRRO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

KRRO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

KRRO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

KRRO

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)